Clinical Trial: Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) in Healthy Volunteers and Outpatients With COVID-19
Study Status: Completed
Recruit Status: Completed
Condition:
Pharmacokinetics
Safety Issues
Efficacy
Study Type: Interventional
Official Title: Multicenter Open Two-stage Study of Pharmacokinetics, Safety and Efficacy of GP30341, 200 mg Capsules (GEROPHARM LLC, Russia) in Healthy Volunteers and Outpatients With Novel Coronavirus Infection 201
Brief Summary:
Pharmacokinetics, safety and efficacy study of GP30341, 200 mg capsules (GEROPHARM LLC, Russia) in healthy volunteers and patients with novel coronavirus infection 2019 (COVID-19) with a high risk of adverse outcome
Read more